June 3, 2010 โ Six-month data from the first 45 patients enrolled in the second stage of a trial for a bioresorbable stent demonstrated strong results. Abbott's bioresorbable vascular scaffold (BVS) showed a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots.
June 3, 2010 โ A joint research agreement will explore the targeted delivery of experimental therapeutics based on ribonucleic acid (RNA) interference (RNAi). Philips Healthcare and RXi Pharmaceuticals Corp. say imaging compounds based on RNAi represent a promising new class of drugs for the targeted treatment of a number of diseases including cancer and cardiovascular disease.
June 3, 2010 โ A single photon emission tomography (SPECT) system may significantly reduce patient and staff radiation exposure by using significantly less radioactive imaging agent.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
June 2, 2010 โ Covidien announced yesterday it is purchasing ev3 Inc. for $2.6 billion to expand its percutaneous vascular portfolio. The company hopes to become a leading endovascular player in both the peripheral vascular and neurovascular markets.
June 2, 2010 โ A portable point-of-care prothrombin time/international normalized ratio (PT/INR) analyzer was released this week. The system detect blood clotting time for patients stabilized on oral anticoagulation medications such as warfarin. The CoaguSense PT/INR monitoring system was recently cleared by the U.S.
June 2, 2010 โ Key research on new diagnostic uses for cardiac ultrasound will be presented at the American Society of Echocardiography (ASE) 21st Annual Scientific Sessions June 12-15, in San Diego. Leading experts in cardiology will present and discuss the latest clinical and research developments in adult and pediatric echocardiography. Among the key presentations are:
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
June 2, 2010 โ Heart failure patients whose treatment was guided by pulmonary artery pressures obtained through a tiny, permanent wireless implant had a 30 percent reduction in hospitalization rates at six months.
June 1, 2010 โ A teleproctoring technology uses robotic technology to teach physicians about new procedures without the additional expense of travel.
June 1, 2010 โ A quadripolar pacing system was recently released in Europe and offers physicians the ability to more effectively manage the ever-changing pacing needs of patients with heart failure.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
June 1, 2010 โ A home sleep testing technology eliminates the need for hospital sleep lab testing, instead monitoring patients in their own beds. The Nihon Kohden Nomad is a type III wearable portable recording device. It offers the ability to record 2 effort, 2 flow, snoring, body position, SpO2, heart rate and leg movements in a lightweight durable casing.
May 27, 2010 โ A single catheter combining both intravascular ultrasound (IVUS) and near-infrared (NIR) spectroscopy to identify lipid-core plaques (LCP) was unveiled at EuroPRC in Paris this week. The device also was demonstrated in live patient cases.
May 27, 2010 โ Positive results from CREST (Carotid Revascularization Endarterectomy vs. Stenting Trial) will be used to expand the U.S. Food and Drug Administration (FDA) indication for carotid stents.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
May 27, 2010 โ The first patient was recently enrolled in the ORBIT II investigational device exemption (IDE) clinical trial to evaluate the safety and effectiveness of its Diamondback 360 atherectomy system in treating calcified coronary arteries.
May 27, 2010 โ One-year data presented this week at EuroPCR in Paris confirms sustained clinical outcomes with Cook Medical's drug-eluting peripheral stent, Zilver PTX.
May 27, 2010 โ New European data from five national clinical registries presented this week at EuroPCR in Paris report positive clinical outcomes for the transcatheter aortic valve implantation for treatment of severe aortic stenosis.